Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  Type 2 DiabetesPsychiatryIssue 681

Association between Smoking and Depression in Type 2 Patients

Smoking and depression are strongly associated in patients with type 2 diabetes....

Advertisement

The study population for the trial included a total of 1,868 adults with type 2 diabetes. Smoking was assessed in the study with five different categories which included: never, former, light (≤10 cigarettes a day) and moderate/heavy (11+ cigarettes a day). Depression was assessed and categorized in the study using a Patient Health Questionnaire. Depression was classified in a binary fashion in this study and patients were recorded as either having no major depression or major depression syndrome. To make sense of the relationship between individual's smoking activity and the presence of depression a statistical analysis using a logistic regression was used, while controlling for other demographic and health-related variables.

After the procedures of the study were carried out, the results showed that major depression was indeed associated with an augmented likelihood of being a smoker in any of the categories (light (≤10 cigarettes a day) and moderate/heavy (11+ cigarettes a day)). Depression; however, was also increased in the patients having 2 or more diabetes complications, moderate-severe disability or having 2 or more other chronic illnesses. In the fully adjusted study model, having major depression was associated with an increased likelihood of being a moderate or heavy smoker (odds ratio = 2.62, 95% confidence interval = 1.43–4.81). The statistical analysis from the study also showed that the association between a light smoker and major depression was not significant when adjusting for confounding variables.

Researchers concluded that smoking and depression are strongly associated in patients with type 2 diabetes. The association between smoking and the presence of major depression syndrome was strongest for diabetic patients classified as either moderate or heavy smokers. These findings potentially mean that depression may be a significant consideration when targeting clients with diabetes who continue to smoke and optimal mental health may not be obtainable until smoking cessation is achieved.

Matthew Clyde, Geneviève Smith, Norbert Gariépy, et al. Canadian Journal of Diabetes. Association between Smoking and Depression in a Canadian Community-Based Sample with Type 2 Diabetes. Vol. 37, Issue 3, June 4, 2013 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 13 June, 2013 and appeared in  Type 2 DiabetesPsychiatryIssue 681

Past five issues: Issue 796 | Diabetes Clinical Mastery Series Issue 255 | Issue 795 | SGLT-2 Inhibitors Special Edition August 2015 | Diabetes Clinical Mastery Series Issue 254 |

2015 Most Popular Articles:

Coffee Consumption Proves Potential in Reducing Type 2 Diabetes Risk
Posted August 07, 2015
Impaired Glucose Uptake in the Brain May Increase Alzheimer's Disease Risk
Posted August 07, 2015
First Non-Surgical Weight Loss Procedure for Mild-to-Moderate Obesity
Posted August 07, 2015
Ketoacidosis Not as Great as Thought in Diabetes Patients Taking Invokana
Posted August 13, 2015
Impact of Switching Insulin Glargine to Insulin Detemir in T2 Patients
Posted August 14, 2015
GLP-1 Agonist Semaglutide Completes Phase III Trial with Positive Results
Posted August 07, 2015
SIgnificant Weight Gain Associated with Laparoscopic Sleeve Gastrectomy
Posted August 14, 2015
Two New Possible Methods for Diagnosing and Monitoring Diabetes
Posted August 07, 2015
Diabetes Combination Drug LixiLan Meets Main Target in Late Stage Trial
Posted August 07, 2015
Soybean Oil Causes More Obesity and Diabetes Than Fructose
Posted August 20, 2015


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
What percentage of your patients have reached goal for A1c, BP and cholesterol?

CME/CE of the Week
Lois Exelbert,
RN, CDE, BC-ADM, LCCE

Category: Nursing
Credits: 1